Scott Worswick, MD, Clinical Associate Professor of Dermatology at Keck Medicine of the University of Southern California, discusses his clinical experience treating Generalized Pustular Psoriasis (GPP) and how targeted therapy with Spesolimab can be used effectively through tailored dosing strategies.
Dr. Worswick highlights two key dosing approaches used in practice: intravenous (IV) administration for acute disease flares and subcutaneous dosing for ongoing maintenance therapy. This combination strategy is designed to rapidly control severe inflammatory episodes while helping reduce the likelihood of future flares.
Topics Covered
- Clinical challenges in managing generalized pustular psoriasis
- Intravenous dosing strategies for acute GPP flares
- Subcutaneous maintenance therapy for long-term disease control
- Real-world treatment outcomes and flare reduction observed with spesolimab
Explore Related Resources
Advancements in the Management Paradigm for Generalized Pustular Psoriasis
Assessing Systemic GPP Treatment With Targeted Therapy
